The National Institute for Health and Care Excellence (NICE) faced "difficult decisions" when it deemed a breast cancer drug which can extend sufferers lives by "up to six months" was too expensive, according to a health expert.
Dr Hilary Jones told Daybreak the £90,000 price tag per patient would have meant taking funds away from other vital services the NHS provides.
More top news
Dippy the Diplodocus is to forced into retirement and moved out of the Natural History Museum's main hall.
Alice Biggar has managed to survive on cheap tins, heavily-reduced supermarket goods and even chicken bones from butchers.
People should go online to report crimes instead of dialling 999, Home Secretary Theresa May has claimed.